Treatment of Gaucher's disease.
作者信息
Barton N W, Brady R O, Dambrosia J M
出版信息
N Engl J Med. 1993 May 27;328(21):1564-5; author reply 1567-8.
PMID:8479496
Abstract
摘要
相似文献
1
Treatment of Gaucher's disease.
N Engl J Med. 1993 May 27;328(21):1564-5; author reply 1567-8.
2
[Enzyme therapy of Gaucher's disease].
Dtsch Med Wochenschr. 1993 Jun 25;118(25):964-5.
3
Treatment regimens in Gaucher's disease.
Lancet. 1995 Aug 26;346(8974):581-2. doi: 10.1016/s0140-6736(95)91422-6.
4
Treatment of Gaucher's disease.
N Engl J Med. 1993 May 27;328(21):1565-6; author reply 1567.
5
Enzyme-replacement therapy for Gaucher's disease.
N Engl J Med. 1991 Dec 19;325(25):1809-11. doi: 10.1056/NEJM199112193252513.
6
Enzyme replacement therapy in type 1 and type 3 Gaucher's disease.
Lancet. 1995 Feb 18;345(8947):451-2. doi: 10.1016/s0140-6736(95)90432-8.
7
Gaucher's disease: therapy by intravenous infusions of modified glucocerebrosidase.
Clin Investig. 1993 Jan;71(1):78. doi: 10.1007/BF00210974.
8
Ceredase dosing concerns for Gaucher's disease.
Am J Med. 1994 Oct;97(4):402-3. doi: 10.1016/0002-9343(94)90314-x.
9
Low-dose versus high-frequency regimens in Gaucher's disease.
Lancet. 1996 Feb 10;347(8998):406-7. doi: 10.1016/s0140-6736(96)90591-7.
10
Hematologic response in type I Gaucher's disease after enzyme replacement therapy.
Haematologica. 1999 Apr;84(4):376-7.
引用本文的文献
1
Alglucerase. A pharmacoeconomic appraisal of its use in the treatment of Gaucher's disease.
Pharmacoeconomics. 1995 Jan;7(1):63-90. doi: 10.2165/00019053-199507010-00007.
2
Alglucerase for Gaucher's disease: dose, costs and benefits.
Pharmacoeconomics. 1994 Jun;5(6):453-9. doi: 10.2165/00019053-199405060-00001.
Zotero 插件